Specify Company / Ticker to Get the Summary
Dividend History IKNA
Dividend Analytics IKNA
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Ikena Oncology Inc
IKNAIkena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210
Analytics
WallStreet Target Price
2.00 USDP/E Ratio
–Dividend Yield
–Financials IKNA
Results | 2019 | Dynamics |